EDBI Logo
|  
Flyout Menu

EDBI

Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept

Portfolio News /

Callio Therapeutics, a biotechnology company focused on realizing the promise of multi-payload antibody-drug conjugates (ADCs) to improve cancer therapy, today announced its launch with the closing of a $187.0 million Series A financing round.

Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept Read More »

Island Announces Participation of Singapore-based Global Investor EDBI in its Series D Round to Accelerate Expansion Plans in the Asia-Pacific Region

Portfolio News /

Island, the Enterprise Browser company, announced the participation of EDBI, the strategic investment arm of the Singapore Economic Development Board, in its previously announced Series D funding round.

Island Announces Participation of Singapore-based Global Investor EDBI in its Series D Round to Accelerate Expansion Plans in the Asia-Pacific Region Read More »

Join our community!

Subscribe to our quarterly e-Newsletter, The Upside to find out what’s shaping the future industries of Singapore and the region.

Subscribe now

Investing in high-growth technologies that shape the future economic pillars of Singapore since 1991.

About EDBI

Team

Portfolio

News and Insights

Careers

Contact Us

Linkedin Youtube

© 2025 EDBI. All rights reserved.